China's Sinovac Vaccine Inadequate Against Omicron Variant, Study Finds

China's Sinovac Vaccine Inadequate Against Omicron Variant, Study FindsПодробнее

Vax Facts: Study shows how quickly vaccines wane against omicronПодробнее

J&J, Sinopharm, Sputnik Vaccines Are Weaker Against Omicron: StudyПодробнее

China says stepping up efforts to develop vaccines against OmicronПодробнее

China’s Sinovac Claims Its Booster Shot Offers 94% Protection AgainstПодробнее

J&J, Sinopharm, Sputnik V COVID-19 shots less effective against Omicron, study showsПодробнее

Brazil study shows China’s Sinovac vaccine less effective than earlier data on the Covid-19 shotsПодробнее

Chinese biotech firm says its Covid treatment is effective against omicron variantПодробнее

Sinovac Vaccine Doesn't Work Against Omicron: StudyПодробнее

Research in China suggests Sinovac vaccine is less effective against variantПодробнее

China Technically Prepared for Developing Vaccines Against Omicron VariantПодробнее

GLOBALink | Sinovac vaccine brings hope to Chile against COVID-19Подробнее

Study: Sinovac's COVID-19 vaccine less effective vs. Gamma variant | ANCПодробнее

Study: Sinopharm's booster jab ineffective against Omicron variant of the COVID-19 | English NewsПодробнее

WHO Omicron alert: spread rate, vaccine efficacy / Latest: China's research on COVID pill treatmentПодробнее

Covid update: ‘Delta variant 40% more transmissible’; China’s vaccine for childrenПодробнее

Sinovac and Sinopharm Prevent from Hospitalization Related to the Omicron VariantПодробнее

How Omicron Challenges U.S. and China on Vaccine Diplomacy | WSJПодробнее

Race Against Time! China speeds up to develop vaccine targeting OmicronПодробнее

COVID-19 vaccine from China’s Sinovac reports 91.25% efficacyПодробнее